Large-scale testing (Phase 3)WithdrawnNCT00502294
What this trial is testing
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
Who this might be right for
Intravenous Steroid-Refractory Ulcerative Colitis
Facet Biotech 150